Aging of the Vascular Wall

Recruiting Observational Study
Vascular Risk Aging Disorder
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
30 (estimated)
Sponsor
Centre Hospitalier Universitaire de Saint Etienne · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Demographic aging is predicted to be one of the most significant social changes of the 21st century. Aging is a slow, multifactorial process that progressively impacts the integrity of cells, tissues, and organs. This decline in function increases the risk of numerous diseases, including cancer, neurodegenerative disorders, and cardiovascular diseases (CVD). CVD, the leading global cause of death,…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Major patients requiring coronary artery bypass grafting (CABG). Exclusion Criteria: * Hypertension, diabetes, systemic inflammatory disease.
Contacts

Anne-Claire DUCHEZ, PhD

(0)477421423

anne-claire.duchez@efs.sante.fr

CONTACT

Salvatore CAMPISI, MD

(0)477829058

salvatore.campisi@chu-st-etienne.fr

CONTACT